Following central motor lesions, two forms of adaptation can be observed which lead to improved mobility: (1) the development of spastic muscle tone, and (2) 
locomotor centers induced by specific treadmill training. Tension development during spastic gait is different from that during normal gait and appears to be independent of exaggerated monosynaptic stretch reflexes. Exaggerated stretch reflexes are associated with an absence or reduction of functionally essential polysynaptic reflexes. When supraspinal control of spinal reflexes is impaired, the inhibition of monosynaptic reflexes is missing in addition to a reduced facilitation of polysynaptic reflexes. Therefore, overall leg muscle activity becomes reduced and less well modulated in (Dietz, 1992) .
Spasticity is associated with numerous physical signs, such as muscle hypertonia and exaggerated tendon reflexes, including clonus. Lance (1980) defined spasticity as a velocity-dependent resistance of muscle to stretch due to the activation of tonic stretch reflexes, while (Gollhofer et al., 1984 Dietz, 1992 (Nacimiento et al., 1993) and is unlikely in man (Ashby 1989 ) as a cause of spasticity. Reduction of pre-synaptic inhibition of group Ia fibers occurs (Burke & Ashby, 1972; Delwaide, 1973; Faist et al., 1994) and seems to correlate with the excitability of tendon reflexes. In addition, after a few weeks, changes in mechanical properties occur in the leg extensor (Dietz et al., 1981) and arm flexor (Ibrahim et al., 1993) (Hufschmidt & Mauritz, 1985; Sinkjaer et al., 1993 (Yarkony et al., 1992; Quintem et al., 1989) .
Treatment of spasticity is usually directed to reduction of stretch reflex activity as it is assumed that exaggerated reflexes are responsible for increased muscle tone and this somehow accounts for the spastic movement disorder. Studies of muscle tone and reflex activity are usually done under passive motor conditions with the patient resting (cf. Thilmann et al., 1990; . On the other hand, extensive investigations of functional movements of leg (Dietz and Berger, 1983; Berger et al. 1984) and arm (Powers et al., 1989; Dietz et al., 1991; Ibrahim et al., 1993) Therapeutic outcomes in spasticity of both spinal and cerebral origin should be considered in terms of physiotherapeutic approaches . These should be directed to train and activate residual motor functions and to prevent secondary complications, such as muscle contractures and spasms. Antispastic drug therapy is the second tool. It reduces muscle tone and spasms by the induction of paresis (Hoogstraten et al., 1988) (Barbeau & Rossignol, 1987;  for review see Barbeau & Fung, 1992) .
Although there is strong evidence for a spinal locomotor generator in many mammals (for review see Grillner, 1981 Barbeau & Rossignol, 1994 , its existence has, until recently, been questioned in man (Kuhn, 1950; Illis, 1995) . Evidence for the human spinal pattem generator was suggested by spontaneously occurring step-like movements (Calancie et al., 1994) and myoclonus (Bussel et al., 1988) , as well as from late flexion reflexes (Bussel et al., 1989) and from locomotor movements induced on a treadmill with body support in paraplegic patients 1995;  for review see Barbeau & Rossignol, 1994) . Recent studies showed that a locomotor pattern can be induced in complete paraplegic patients when leg movements were assisted externally (Dietz et al., , 1995 Dobkin et al., 1995) . Nevertheless, the amplitude of leg muscle EMG activity in these patients was small compared to healthy subjects, (most probably due to the loss of noradrenergic influences from brainstem centers) such that no leg movements resulted from this leg muscle activation.
The beneficial effect of locomotor training in incomplete paraplegic patients is well established (Fung et al., 1990; Wemig & Miiller, 1992 ; for review see Barbeau & Rossignol, 1994) (Dietz et al., 1998a,b) . Therefore, the improvements of locomotor function described earlier for cat (Barbeau & Rossignol, 1987) and man (Wemig & Miiller, 1992; Barbeau & Rossignol, 1994 ;)can be partially attributed to non-specific effects on the locomotor apparatus, i.e. muscular tendon-systems.
Body unloading is obviously of crucial importance to induce training effects on the locomotor centers. The range of body unloading that allows stepping movements and optimal activation of leg muscles for body support by the legs during the stance phase is limited in paraplegic patients. Afferent input from receptors signaling contact forces during the stance phase is essential for the activation of spinal locomotor centers (of. Harkema et al., 1997) , and therefore it should also be important for the training effects described here. Although the amplitude of leg extensor EMG in both paraplegic and healthy subjects depends upon the actual body load during the stepping movements, the absolute level of EMG activity is considerably lower in patients than in healthy subjects. This makes the body unloading necessary for the locomotor training. There is, indeed, increasing evidence in cat (Pearson & Collins, 1993) and man for a contribution of load receptors to the activation of leg extensors during stance and locomotion.
Recovery of spinal cord function and locomotion
Recent studies have shown that during locomotor training gastrocnemius (GM), EMG activity increases during the stance phase, even in complete paraplegic patients (Dietz et al., 1995 (Katho & E1 Masry, 1994; Curt & Dietz, 1996; 1998 (Dietz et al., 1998a, b In addition, one might argue that the increase of GM EMG during the course of training is mainly due to the decrease of body unloading. However, after statistical separation of the (un)loading effect, there remained a significant effect of training. Therefore, one may conclude that there are specific training effects on spinal locomotor centers which can lead to an improvement of locomotor function in paraplegic patients (Dietz et al., 1998 a,b) .
Looking ahead it may be important to discover new means to further enhance the amplitude of leg extensor EMG activity in complete or almost complete paraplegic patients in order to achieve an even greater mobility in such patients. This may be achieved by the application of new noradrenergic drugs which have a more selective action on EMG activity compared to the ones already applied (clonidine and epinephrine, see Dietz et al., 1995) . The most promising approach may, however, be to induce some regeneration of corticospinal axons within the spinal cord. Recent experiments in rats (Bregman et al., 1995) 
